Ice cream products distributed in retail stores in nine American states have been recalled due to potential Listeria contamination, according to the United States Food and Drug Administration.
The states involved were New York, Massachusetts, Connecticut, Rhode Island, Vermont, Louisiana, Florida, Texas, and New Hampshire.
The recall was initiated by Royal Ice Cream after FDA sampling revealed Listeria monocytogenes' presence on processing equipment. It has expanded its recall to include all products manufactured at the facility within expiry.
Listeria monocytogenes is an organism that can cause serious and sometimes fatal infections in the young, frail or the elderly, and others with weakened immune systems.
Although healthy individuals may only experience short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can also cause miscarriages and stillbirths among pregnant women.
Officials say all affected products will have the manufacturing plant number “CT121” or “CT#121”.
The affected brands were Royal Ice Cream, Batch brand, Ronny Brook Ice cream, New Orleans Ice cream, Maple Valley Ice Cream, Art Cream, Sweet Scoops Yogurt, Gelato Fiasco, Biggy Iggy’s Ice Cream Sandwiches, Munson Chip Wich Ice Cream sandwiches, Giffords Ice cream Sandwiches, Chewy Louie Ice Cream Sandwiches, Snow Wich Ice Cream Sandwich, and Newport Creamery.
So far, no illnesses have been reported related to the product. Those who have purchased the affected products are urged to return them to the place of purchase for a full refund.


Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Oil Prices Hold Steady as Ukraine Tensions and Fed Cut Expectations Support Market
Visa to Move European Headquarters to London’s Canary Wharf
Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
RBI Cuts Repo Rate to 5.25% as Inflation Cools and Growth Outlook Strengthens
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 



